DIRMC: a database of immunotherapy-related molecular characteristics

被引:0
|
作者
Liu, Yue [1 ]
Zhou, Yuhuan [2 ]
Hu, Xiumei [3 ]
Le-Ge, Wuri [4 ]
Wang, Haoyan [1 ]
Jiang, Tao [1 ]
Li, Junyi [2 ]
Hu, Yang [1 ]
Wang, Yadong [1 ]
机构
[1] Harbin Inst Technol, Fac Comp, Harbin 150001, Heilongjiang, Peoples R China
[2] Harbin Inst Technol Shenzhen, Sch Comp Sci & Technol, Shenzhen 518055, Guangdong, Peoples R China
[3] Beidahuang Ind Grp Gen Hosp, Harbin 150001, Peoples R China
[4] Tongliao City Hosp, Dept Pain, Tongliao 028000, Peoples R China
来源
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION | 2024年 / 2024卷
基金
中国国家自然科学基金;
关键词
D O I
10.1093/database/baae032
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cancer immunotherapy has brought about a revolutionary breakthrough in the field of cancer treatment. Immunotherapy has changed the treatment landscape for a variety of solid and hematologic malignancies. To assist researchers in efficiently uncovering valuable information related to cancer immunotherapy, we have presented a manually curated comprehensive database called DIRMC, which focuses on molecular features involved in cancer immunotherapy. All the content was collected manually from published literature, authoritative clinical trial data submitted by clinicians, some databases for drug target prediction such as DrugBank, and some experimentally confirmed high-throughput data sets for the characterization of immune-related molecular interactions in cancer, such as a curated database of T-cell receptor sequences with known antigen specificity (VDJdb), a pathology-associated TCR database (McPAS-TCR) et al. By constructing a fully connected functional network, ranging from cancer-related gene mutations to target genes to translated target proteins to protein regions or sites that may specifically affect protein function, we aim to comprehensively characterize molecular features related to cancer immunotherapy. We have developed the scoring criteria to assess the reliability of each MHC-peptide-T-cell receptor (TCR) interaction item to provide a reference for users. The database provides a user-friendly interface to browse and retrieve data by genes, target proteins, diseases and more. DIRMC also provides a download and submission page for researchers to access data of interest for further investigation or submit new interactions related to cancer immunotherapy targets. Furthermore, DIRMC provides a graphical interface to help users predict the binding affinity between their own peptide of interest and MHC or TCR. This database will provide researchers with a one-stop resource to understand cancer immunotherapy-related targets as well as data on MHC-peptide-TCR interactions. It aims to offer reliable molecular characteristics support for both the analysis of the current status of cancer immunotherapy and the development of new immunotherapy. DIRMC is available at http://www.dirmc.tech/.Database URL: http://www.dirmc.tech/
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Hypoproteinemia being a manifestation of immunotherapy-related liver dysfunction
    Deng, Juan
    Chen, Xiaoxia
    Sun, Hui
    Liu, Yu
    Li, Wei
    Chen, Bin
    Zhao, Sha
    Jia, Keyi
    Wang, Hao
    Guo, Haoyue
    Jiang, Minlin
    Xu, Yi
    He, Yayi
    Zhou, Caicun
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (14)
  • [32] Immunotherapy-Related Publications in Colorectal Cancer: A Bibliometric Analysis
    Sur, Daniel
    Lungulescu, Cristina
    Puscariu, Irina-Ioana
    Volovat, Simona Ruxandra
    Preda, Madalina
    Mateianu, Elena Adriana
    Lungulescu, Cristian Virgil
    HEALTHCARE, 2022, 10 (01)
  • [33] Myxoedema coma caused by immunotherapy-related thyroiditis and enteritis
    Mc Donald, Darran
    Goulden, Eirena
    Cullen, Garret
    Crown, John
    Crowley, Rachel K.
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2021, 2021
  • [34] Cancer immunotherapy-related adverse events: causes and challenges
    Blidner, Ada G.
    Choi, Jennifer
    Cooksley, Tim
    Dougan, Michael
    Glezerman, Ilya
    Ginex, Pamela
    Girotra, Monica
    Gupta, Dipti
    Johnson, Douglas
    Shannon, Vickie R.
    Suarez-Almazor, Maria
    Rapoport, Bernardo L.
    Anderson, Ronald
    SUPPORTIVE CARE IN CANCER, 2020, 28 (12) : 6111 - 6117
  • [35] Immunotherapy-mediated valvulitis: a new cardiovascular immunotherapy-related adverse event
    Wassif, Heba
    Hussain, Muzna
    Collier, Patrick H.
    Moudgil, Rohit
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2020, 21 (10) : 1102 - 1102
  • [36] Immunotherapy-Related Cystitis: Case Report and Review of the Literature
    Zhu, Liping
    Wang, Zhiqiang
    Stebbing, Justin
    Wang, Zibing
    Peng, Ling
    ONCOTARGETS AND THERAPY, 2021, 14 : 4321 - 4328
  • [37] Factors Associated with Allergen Immunotherapy-Related Systemic Reactions
    Arja, Sowmya
    Licata, Christine
    Nguyen, Anh
    Stocking, Jacqueline
    Teuber, Suzanne
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB47 - AB47
  • [38] Unique and distinctive histological features of immunotherapy-related thyroiditis
    Zaborowski, Matthew
    Sywak, Mark
    Nylen, Carolina
    Gill, Anthony J.
    Chou, Angela
    PATHOLOGY, 2020, 52 (02) : 271 - 273
  • [39] Immunotherapy-related acute kidney injury: Kidney biopsy or not?
    Chatterton, Sophie
    Williams, Sarah
    Nahar, Kazi
    Menzies, Alexander M.
    Wong, Muh G.
    NEPHROLOGY, 2021, 26 (01)
  • [40] REACTIVATION OF LATENT TUBERCULOSIS: IMMUNOTHERAPY-RELATED OR STEROID-INDUCED?
    Miyazaki, Kyle
    Kim, Jean
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S523 - S523